Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 1.36 million. The enterprise value is -832,458.
| Market Cap | 1.36M |
| Enterprise Value | -832,458 |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.34 million shares outstanding. The number of shares has increased by 70.54% in one year.
| Current Share Class | 11.34M |
| Shares Outstanding | 17.34M |
| Shares Change (YoY) | +70.54% |
| Shares Change (QoQ) | +3.04% |
| Owned by Insiders (%) | 34.86% |
| Owned by Institutions (%) | 1.00% |
| Float | 9.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.57 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.25 |
| Quick Ratio | 3.02 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -94.04 |
Financial Efficiency
Return on equity (ROE) is -64.70% and return on invested capital (ROIC) is -36.09%.
| Return on Equity (ROE) | -64.70% |
| Return on Assets (ROA) | -27.33% |
| Return on Invested Capital (ROIC) | -36.09% |
| Return on Capital Employed (ROCE) | -60.77% |
| Revenue Per Employee | 106,106 |
| Profits Per Employee | -19,181 |
| Employee Count | 94 |
| Asset Turnover | 2.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.04% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 46.00 |
| Average Volume (20 Days) | 4,817 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.62 |
Income Statement
In the last 12 months, Syra Health had revenue of 8.06 million and -1.46 million in losses. Loss per share was -0.14.
| Revenue | 8.06M |
| Gross Profit | 2.47M |
| Operating Income | -1.47M |
| Pretax Income | -1.46M |
| Net Income | -1.46M |
| EBITDA | -1.42M |
| EBIT | -1.47M |
| Loss Per Share | -0.14 |
Balance Sheet
The company has 2.31 million in cash and 108,879 in debt, giving a net cash position of 2.20 million or 0.13 per share.
| Cash & Cash Equivalents | 2.31M |
| Total Debt | 108,879 |
| Net Cash | 2.20M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 2.41M |
| Book Value Per Share | 0.14 |
| Working Capital | 2.38M |
Cash Flow
| Operating Cash Flow | -666,133 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.58%, with operating and profit margins of -18.19% and -18.08%.
| Gross Margin | 30.58% |
| Operating Margin | -18.19% |
| Pretax Margin | -18.08% |
| Profit Margin | -18.08% |
| EBITDA Margin | -17.63% |
| EBIT Margin | -18.19% |
| FCF Margin | n/a |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -70.54% |
| Shareholder Yield | n/a |
| Earnings Yield | -106.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Syra Health has an Altman Z-Score of 2.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.42 |
| Piotroski F-Score | 3 |